Clinical trial

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment…

NCT00126906 · Centers for Disease Control and Prevention, U.S. Fed · Completed

Key facts

NCT number NCT00126906
Title Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi
Official title Intermittent Preventive Treatment With Sulfadoxine/Pyrimethamine During Pregnancy Among HIV-Positive and HIV-Negative Women: 2-Dose Versus Monthly - Malawi
Lead sponsor Centers for Disease Control and Prevention, U.S. Fed
Collaborators Ministry of Health and Population, Malawi
Status Completed
Study type Interventional
Conditions Malaria, Falciparum, HIV Infections
Intervention type Drug
Interventions Monthly sulfadoxine/pyrimethamine, 2-dose sulfadoxine/pyrimethamine
Enrollment 700
Start date Oct 1, 2002
Completion Mar 1, 2005
First posted Aug 5, 2005
Last update posted Aug 23, 2005
Countries Malawi

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies